Sun.Apr 07, 2024

article thumbnail

Cell Therapies and their Legal Discontents

Bill of Health

In February, the news broke that the Food and Drug Administration (FDA) had approved a “first of its kind” new cancer therapy. Iovance’s AMTAGVI TM , the subject of the approval, is a personalized immunotherapy for advanced melanoma. To be treated, adult patients who are ineligible for surgery or have metastatic disease provide their tumor cells to their medical team.

FDA 111
article thumbnail

Bonus Features – April 7, 2024 – 86% of health systems had at least 10% of nurses quit in 2023, 25% of providers intend to deploy generative AI for patient engagement, plus 21 more stories

Healthcare IT Today

Welcome to the weekly edition of Healthcare IT Today Bonus Features. This article will be a weekly roundup of interesting stories, product announcements, new hires, partnerships, research studies, awards, sales, and more. Because there’s so much happening out there in healthcare IT we aren’t able to cover in our full articles, we still want to make sure you’re informed of all the latest news, announcements, and stories happening to help you better do your job.

Nurses 101
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

March’s Most Played Episodes

HealthIT Answers

Don’t miss the top three most played episodes on our SoundCloud channel in the month of March including two of our popular podcasts and one of our radio shows. Combined these three episodes have over 877 plays! The post March’s Most Played Episodes appeared first on Health IT Answers.

64
article thumbnail

Capitation Rates Announcement for CY 2025

Innovaare Compliance

The Centers for Medicare & Medicaid Services (CMS) officially announced capitation rates for Medicare Advantage (MA) plans for CY 2025 – average increase of 3.7% or $16 billion in 2025 over 2024 in expected MA payments. CMS explains, in details, the derivation of the rate increases in the April 1, 2024 final announcement – changes in STAR rating measures are expected to decrease bonus payments to MA plans by 0.11%, risk model revision and normalization will trim rates by 2.45%, compare

article thumbnail

Navigating the Future: Generative AI, Application Analytics, and Data

Generative AI is upending the way product developers & end-users alike are interacting with data. Despite the potential of AI, many are left with questions about the future of product development: How will AI impact my business and contribute to its success? What can product managers and developers expect in the future with the widespread adoption of AI?

article thumbnail

Burda on Healthcare: The Numbers Don’t Add Up for Patient Safety

HealthIT Answers

By David R. Burda - When we last used this column to visit the topic of patient safety, things were bleak. In “Dead Patient Walking,” we argued that patients are at risk before they even receive care from such things as supply chain shortages, poor EHR systems, cybersecurity attacks and prior authorization delays. The post Burda on Healthcare: The Numbers Don’t Add Up for Patient Safety appeared first on Health IT Answers.

59
article thumbnail

Rate Announcement for CY 2025

Innovaare Compliance

The Centers for Medicare & Medicaid Services (CMS) officially announced capitation rates for Medicare Advantage (MA) plans for CY 2025 – average increase of 3.7% or $16 billion in 2025 over 2024 in expected MA payments. CMS explains, in details, the derivation of the rate increases in the April 1, 2024 final announcement – changes in STAR rating measures are expected to decrease bonus payments to MA plans by 0.11%, risk model revision and normalization will trim rates by 2.45%, compare